Detoxification and Activating Blood Circulation Decoction Promotes Reendothelialization of Damaged Blood Vessels via

Zhiming Liu1, Guangmei Xie1, Zuwei Li2

  • 1Jiangxi University of Chinese Medicine.

Insights

Detoxification and Activating Blood Circulation Decoction (DABCD) promotes vascular reendothelialization after angioplasty by increasing miR-126a-5p. This traditional Chinese medicine inhibits in-stent restenosis by modulating the vascular endothelial growth factor (VEGF) pathway.

Area of Science:

  • Cardiovascular Research
  • Pharmacology
  • Molecular Biology

Background:

  • In-stent restenosis (ISR) following percutaneous coronary intervention (PCI) is a significant clinical issue.
  • Promoting vascular reendothelialization is crucial for preventing endothelial proliferation and ISR.
  • Understanding the molecular mechanisms underlying therapeutic interventions is essential.

Purpose of the Study:

  • To elucidate the mechanism by which Detoxification and Activating Blood Circulation Decoction (DABCD) promotes vascular reendothelialization.
  • To investigate the role of miRNA-126 in DABCD's effect on ISR.
  • To determine DABCD's impact on the vascular endothelial growth factor (VEGF) signaling pathway.

Main Methods:

  • A rat model of post-PCI restenosis was established using balloon-induced aortic injury.
  • Vascular tissue and serum were collected at 14 and 28 days post-injury.
  • Levels of nitric oxide (NO), endothelin-1 (ET-1), miR-126a-5p, endothelial nitric oxide synthase (eNOS), VEGF, p-Akt, and p-ERK were analyzed.

Main Results:

  • DABCD treatment significantly reduced intimal hyperplasia and inflammation in the injured aorta.
  • DABCD promoted vascular reendothelialization, increased nitric oxide (NO) production, and decreased ET-1 levels.
  • DABCD upregulated miR-126a-5p, eNOS mRNA, and VEGF, p-Akt, and p-ERK protein expression in vascular tissue.

Conclusions:

  • DABCD effectively promotes vascular reendothelialization and inhibits neointimal formation after arterial injury.
  • The therapeutic effects of DABCD are mediated, in part, by the miR-126-mediated activation of the VEGF signaling pathway.
  • DABCD represents a potential therapeutic strategy for preventing in-stent restenosis.